Navigation Links
China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2013
Date:2/26/2013

HONG KONG, Feb. 26, 2013 /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced its preliminary unaudited financial results for the third quarter and first nine months of fiscal year 2013, which ended December 31, 2012.

Third Quarter of Fiscal 2013 Highlights

  • Revenues for the third quarter of fiscal 2013 increased by 57.5% to RMB149.3 million ($24.0 million) from RMB94.8 million in the prior year period.
  • New subscriber sign-ups increased 65.0% year-over-year to 21,218.
  • Accumulated subscriber base amounted to 295,923.
  • Gross profit increased by 65.6% to RMB121.1 million ($19.4 million) from RMB73.1 million in the prior year period.
  • Gross margin was 81.1%, an increase from 77.1% in the prior year period.
  • Operating income increased by 112.9% to RMB67.1 million ($10.8 million) from RMB31.5 million in the prior year period.
  • Interest expense amounted to RMB23.8 million ($3.8 million), compared to RMB0.7 million in the prior year period.
  • Income before income tax for the third quarter grew by a lesser extent of 29.7% because of higher interest expense and lack of exchange gain.
  • Net income attributable to the Company was RMB33.6 million ($5.4 million), a decrease of 14.8% compared to the same period last year also due to higher interest expense and lack of exchange gain and a one-time tax benefit recorded in the third quarter of fiscal 2012.  
  • Operating cash inflow for the quarter amounted to RMB144.1 million ($23.1 million).
  • First Nine Months of Fiscal 2013 Highlights

  • Revenues for the first nine months of fiscal 2013 increased by 40.0% to RMB393.1 million ($63.1 million) f
    '/>"/>

  • SOURCE China Cord Blood Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related biology technology :

    1. China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2013 Financial Results
    2. China Cord Blood Corporation Announces Completion of Corporate Structure Consolidation
    3. Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
    4. Lucintel’s Analysis of Growth Opportunities in China’s Composites Industry: Expect Market to Surpass $11 Billion in 2017
    5. China Cord Blood Corporation to Further Consolidate its Corporate Structure
    6. Biomaterials China News 1210 - Annual Subscription
    7. China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2013
    8. China Cord Blood Corporation Announces Completion of Strategic Partnership with Cordlife Group Limited
    9. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2013 Financial Results
    10. China Biologic Products to Report Third Quarter 2012 Financial Results
    11. Life Technologies New State-of-the-Art Manufacturing Facility in China Provides Forensics Labs Rapid Access to World-Leading DNA Testing Solutions
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... Freeslate, Inc ., the leading ... Lupin Limited, one of India’s top five pharmaceutical companies, ... System for high throughput solid form screening. ... a wide range of quality, affordable generic and branded ...
    (Date:1/14/2014)... 14, 2014 Histogen, Inc., a regenerative ... cells grown under simulated embryonic conditions, today announced that ... Suneva Medical, Inc. for physician-dispensed aesthetic products containing Histogen’s ... This agreement is an amendment to the existing license ...
    (Date:1/14/2014)... SAN DIEGO and BETHESDA, Md. ... they are joining together with two institutes from the ... more reliable tools for bringing safer, more effective treatments ... with the National Center for Advancing Translational Sciences (NCATS) ...
    (Date:1/14/2014)...   Kinaxis ®, provider of RapidResponse ®, a cloud-based ... planning ( S&OP ) service, is proud to be a ... be held at the Hilton San Diego Bayfront, January 30 ... Elisabeth Kaszas , Director of Supply Chain at Amgen, as ...
    Breaking Biology Technology:Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2
    ... Romark Laboratories announced results from its STEALTH C-3 clinical trial, ... genotype 1 chronic hepatitis C.  Study results were presented this afternoon ... American Gastroenterological Association Institute (AGA Institute) during Digestive Disease Week 2010 ... , , ...
    ... ... on leak testing procedures through the roll-out of a global Summer seminar ... and revolutionise current packaging test methods within the pharmaceutical industry. , ... Belfast (Vocus) May 5, 2010 -- ...
    ... , NEWTON, Mass. , May 4 Microfluidics International Corporation (OTC ... on Tuesday, May 11, 2010 , at 8:30am ET . , ... (Logo:   http://www.newscom.com/cgi-bin/prnh/20090811/NE59652LOGO ) , ... Michael C. Ferrara , President and Chief Executive Officer, and Peter ...
    Cached Biology Technology:Romark Announces Final Data From Clinical Trial of Nitazoxanide in Treatment-Naive Patients With Genotype 1 Chronic Hepatitis C 2Romark Announces Final Data From Clinical Trial of Nitazoxanide in Treatment-Naive Patients With Genotype 1 Chronic Hepatitis C 3Romark Announces Final Data From Clinical Trial of Nitazoxanide in Treatment-Naive Patients With Genotype 1 Chronic Hepatitis C 4Romark Announces Final Data From Clinical Trial of Nitazoxanide in Treatment-Naive Patients With Genotype 1 Chronic Hepatitis C 5Pharmaceutical Leak Testing Practices challenged by SEPHA 2Pharmaceutical Leak Testing Practices challenged by SEPHA 3Microfluidics International Corporation to Report First Quarter 2010 Financial Results on May 11, 2010 2Microfluidics International Corporation to Report First Quarter 2010 Financial Results on May 11, 2010 3
    (Date:4/17/2014)... NY, April 17, 2014The development of stem cell therapies ... ability to characterize stem cell populations based on cell ... discovered a new marker that is highly expressed in ... cord blood, which they describe in an article in ... Mary Ann Liebert, Inc., publishers. The article is available ...
    (Date:4/17/2014)... consumption advisories for expecting mothers are ineffective in ... organic pollutants (POPs). , The study, performed ... Toronto Scarborough PhD student Matt Binnington and Professor ... environmental contamination, a mother,s compliance with advisories, and ... exposure in her children. , Their model estimates ...
    (Date:4/17/2014)... anthrax detection cartridge developed at Sandia National Laboratories and ... easier, faster and cheaper. , Bacillus anthracis ... in soils all over the world and can cause ... animals. The bacteria can survive in harsh conditions for ... may occur through skin contact, inhalation of spores or ...
    Breaking Biology News(10 mins):Fish consumption advisories fail to cover all types of contaminants 2Pocket-sized anthrax detector aids global agriculture 2Pocket-sized anthrax detector aids global agriculture 3
    ... of two species oscillate together (for example, predators and prey), ... A famous example is the Canadian lynx and snowshoe hare, ... But is the opposite also true" If the preys population ... are not tightly linked in the food web" Among ecologists, ...
    ... experimental model used to simulate astronaut weightlessness in space ... effects of stress on immune organs. Earlier ... the protein osteopontin (OPN) in bone mineral loss associated ... possible by the creation at Rutgers of a mouse ...
    ... many archaeologists believed to be descended from European wild ... Stone Age farmers, new research suggests. The research ... University, which is published today in the academic journal ... mitochondrial DNA from ancient and modern pig remains. Its ...
    Cached Biology News:Hidden interactions between predators and prey: evolution causes cryptic dynamics in ecology 2Mice stressed in simulated weightlessness show organ atrophy 2Mice stressed in simulated weightlessness show organ atrophy 3Pig study sheds new light on the colonisation of Europe by early farmers 2
    a1-Antitrypsin (human, alpha-1 AT)...
    ... vesicles are used to study co-translational ... Processing events such as signal peptide ... glycosylation can be examined by the ... vitro in the presence of these ...
    ... using Mo Bio luciferase assay. Mo Bio Laboratories ... will allow you to certify your products ATP-Free ... you to deliver them to your customers in ... limit is 3.5 x 10-12 /l, which will ...
    ... New Concept in Microarrays: Biomedical Photometrics Inc. ... GmbH (Jena, Germany) have collaborated to develop ... ArrayTube System. The DNAscope AT is ... new DNAscope AT automatically reads up to ...
    Biology Products: